Why I would buy and hold these shares for a decade

The Altium Limited (ASX:ALU) share price is one of two which I think could climb notably higher in the long-term…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to finding shares to buy and hold for an extended period, I think the healthcare and information technology sectors are great places to start looking.

While there are a large number of quality options in both sectors, I have picked out my current favourites below.

Here's why I think they are great buy and hold investment candidates:

Altium Limited (ASX: ALU)

Although its shares have almost tripled in value since this time last year, I still believe that Altium could prove to be a great buy and hold investment. The printed circuit board (PCB) design software provider looks set to be a big winner from the rise of the Internet of Things market. As the majority of devices that connect to the internet require a PCB inside them, I expect demand for Altium's software will continue to increase significantly.

This increasing demand was evident when Altium released its half-year results last week. The software company reported half-year revenue growth of 30% to US$63.2 million, earnings before interest, tax, depreciation and amortisation growth of 51% to US$19 million, and net profit after tax growth of 51%. I believe this puts it well on course to achieve its revenue target of US$200 million by FY 2020.

CSL Limited (ASX: CSL)

This biopharmaceutical company is my favourite healthcare share on the Australian share market just ahead of private hospital operator Ramsay Health Care Limited (ASX: RHC). I thought CSL's first-half result was a highlight of earnings season and demonstrated why it could be a stand out buy and hold investment option.

CSL reported a 31% lift in net profit after tax to surpass US$1 billion for the first time in half. This was driven by strong sales from its immunoglobulin and seasonal flu vaccine products. While the second-half is likely to be softer due to seasonal factors, I still expect a stellar full-year result that justifies the premium its shares trade at today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »